AsiaTIDES: Oligonucleotide and Peptide
View Full Event Details
Including:
- Regulatory Updates: Preclinical Safety Assessment of Oligonucleotides and Peptides including Reports from JPMA and the Oligonucleotide Safety Working Group on ICH S6 and Off Target Effects
- miRNA, Oligonucleotides, Peptides and Peptide Vaccines: Updates on therapeutic candidates in preclinical and clinical development
- Manufacturing and analytical development strategies to speed process development
- Formulation and delivery updates to help gauge product marketability
In-Depth Tutorials:
- Technical and Regulatory Aspects of Peptide Specifications and Characterization: From Preclinical through to Market Application
- Strategies and Approaches for in vivo Delivery of Oligonucleotides
Article Views: 75
Sign in Area
Additional Sign In options
Site Breadcrumb
You are here :
Please note that to comment on an article you must be registered and logged in.
Registration is for free, you may already be registered to receive, e.g., the newsletter. When you register on this website, please ensure you view our terms and conditions. All comments are subject to moderation.